The region marked A demonstrates the pathognomonic perfusion signature of the ischemic penumbra: preserved or increased CBV with decreased CBF. This mismatch occurs because cerebral autoregulation responds to reduced arterial inflow by triggering downstream arteriolar vasodilation, which increases cerebral blood volume while flow remains compromised. This tissue is electrically silent but metabolically viable—the definition of salvageable penumbra. Per the AHA/ASA 2019 guidelines and the DAWN and DEFUSE-3 trials, identification of this CBV-CBF mismatch with prolonged MTT/Tmax is the cornerstone of patient selection for mechanical thrombectomy in the extended window (6–24 hours), where a mismatch ratio ≥1.8 and absolute mismatch ≥15 mL with core <70 mL predicts benefit from reperfusion therapy.
AHA/ASA Stroke Guidelines 2019; DAWN, DEFUSE-3 trials
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.